Rxedia Meditech Private Limited

Rxedia Meditech Private Limited - healthcare in Thane, Maharashtra, India. FY 2026 financials & compliance.
CIN U72300MH2011PTC222452 Incorporated 27 September 2011 ROC Mumbai HQ Thane, Maharashtra, India
Active Private Limited Company healthcare
Revenue · FY 2024
₹21,466
▼ 4% YoY
Net profit · FY 2024
₹2,489
Net margin 11.6%
EBITDA · FY 2024
₹2,489
EBITDA margin 11.6%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
15 yrs
Est. 2011
Directors on board
3
As per MCA filings
Brands
1
Associated brands

About Rxedia Meditech Private Limited

Data last updated:

Rxedia Meditech Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 27 September 2011 and has been in existence for over 15 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U72300MH2011PTC222452.

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Babaljit Kaur and Sarbpal Chitwarn Singh.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 43 Surya Shopping Center Srishti Complex Mira Road (E), Thane, Maharashtra, India – 401107.

As per the financials filed for FY 2024, the company reported a revenue of ₹21,466, a decline of 4% compared to the previous year. For the same year it recorded a net profit of ₹2,489 (net margin 11.6%) and EBITDA of ₹2,489 (EBITDA margin 11.6%). Revenue has declined at a compounded annual rate (CAGR) of 59% over three years and 41% over five years.

The company is associated with 1 brand: Rxedia.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U72300MH2011PTC222452
Registration Number 222452
Incorporation Date 27 September 2011
ROC Mumbai
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

Contact details

Rxedia Meditech Private Limited's registered office is in Thane, Maharashtra. Its e-mail address is in the company report.

  • Email
  • Registered Address
    43 Surya Shopping Center Srishti Complex Mira Road (E), Thane, Maharashtra, India – 401107
  • Industry
    Healthcare, Diagnostic Centers & Pathology Labs

To see the full contact details of Rxedia Meditech Private Limited, buy the company report.

Comprehensive company report
Rxedia Meditech Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Rxedia Meditech operates one associated brand: Rxedia. Each brand links to its own profile.

BrandDescriptionWebsite
Free tool for effortless patient and clinic management activities.rxedia.com

Business activity

The main business activity of Rxedia Meditech is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Rxedia Meditech Private Limited, buy the company report.

Financials of Rxedia Meditech Private Limited

FY 2025 filings available

Rxedia Meditech Private Limited reported revenue of ₹21,466 (down 4% YoY) for FY 2024.

Revenue · FY 2024
₹21,466 ▼ 4%
Net profit · FY 2024
₹2,489 margin 11.6%
EBITDA · FY 2024
₹2,489 margin 11.6%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 4%
3 years · compounded
▼ 59%
5 years · compounded
▼ 41%
EBITDA CAGR growth
1 year
▼ 29%
3 years · compounded
▲ 42%
5 years · compounded
▲ 18%

Revenue has declined at a compounded annual rate (CAGR) of 41% over five years, including a 4% fall in the latest year. EBITDA fell 29% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹2,489
Profit Before Tax
Tax Expense
Net Profit (PAT)₹2,489
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin11.6%
Net Profit Margin11.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Rxedia Meditech Private Limited, buy the company report.

Board of directors of Rxedia Meditech Private Limited

Rxedia Meditech has 3 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Babaljit KaurDirector27 Sep 201115 Years 1 MonthsCurrent
Sarbpal Chitwarn SinghDirector27 Sep 201115 Years 1 MonthsCurrent
Amritpal Chitwarn SinghDirector27 Sep 201115 Years 1 MonthsCurrent

Auditor

Rxedia Meditech Private Limited is audited by RITESH BURAD & CO for the financial year 2020.

Auditor firmFinancial yearFirm registration number
RITESH BURAD & COFY 2020117936W

Shareholding

The shareholding of Rxedia Meditech Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2020FY 2016FY 2015
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Rxedia Meditech Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Rxedia Meditech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Rxedia Meditech Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Rxedia Meditech Private Limited has 3 board changes on record since 2011: 3 appointments. The latest: Amritpal Chitwarn Singh was appointed as Director on 27 Sep 2011.

AGM
Rxedia Meditech Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Rxedia Meditech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Appointed
Amritpal Chitwarn Singh was appointed as Director.
Appointed
Babaljit Kaur was appointed as Director.
Appointed
Sarbpal Chitwarn Singh was appointed as Director.
Incorporation
27 Sep 2011
Rxedia Meditech Private Limited was registered on 27 Sep 2011 with Roc Mumbai Ii & aged 15 years 1 month as per MCA records.

Frequently asked questions

Rxedia Meditech is an active private limited company based in Thane, Maharashtra, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 27 September 2011 (15+ years old) and is registered under CIN U72300MH2011PTC222452.

Rxedia Meditech has 3 current directors:

The latest financial statements of Rxedia Meditech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The CIN (Corporate Identification Number) of Rxedia Meditech is U72300MH2011PTC222452. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Rxedia Meditech was incorporated on 27 September 2011, making it 15+ years old. It is registered with the Registrar of Companies, Mumbai.

Amritpal Chitwarn Singh was appointed as Director on 27 Sep 2011. Babaljit Kaur was appointed as Director on 27 Sep 2011. Sarbpal Chitwarn Singh was appointed as Director on 27 Sep 2011.

The registered office of Rxedia Meditech is at 43 Surya Shopping Center Srishti Complex Mira Road E, Thane, Maharashtra, India – 401107.

Rxedia Meditech operates in the healthcare industry, in the diagnostic centers and pathology labs segment.

The compliance status of Rxedia Meditech is compliant as of 15 August 2026. The company is actively filing with the Registrar of Companies.

Rxedia Meditech has 1 associated brand: Rxedia.